quinazolines has been researched along with Cardiovascular Stroke in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (56.41) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (20.51) | 29.6817 |
2010's | 9 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harmann, LM; Meyer, J; Petersen, M; Routhu, KV; Sonin, DL; Strande, JL; Wakatsuki, T | 1 |
Schaaf, M; Sibellas, F | 1 |
Beyer, EC; Dudley, SC; Efimov, IR; Gemel, J; Greener, ID; Liu, H; Ng, FS; Rutledge, CA; Sergeyenko, AM; Sovari, AA; Sulkin, MS | 1 |
Birnbaum, Y; Kodakandla, M; Ling, S; Nanhwan, MK; Nylander, S; Ye, Y | 1 |
Cai, MX; Chen, T; Du, SJ; Lin, QQ; Shi, XC; Tan, ZN; Tian, ZJ | 1 |
Bartha, E; Habon, T; Halmosi, R; Hideg, K; Kálai, T; Kalman, E; Kiss, GN; Kulcsár, G; Sumegi, B; Toth, K | 1 |
Vetter, C | 1 |
Kickler, TS; Lynch, DR; Rade, JJ | 1 |
Beijnen, JH; Lankheet, NA; Malingré, MM; Schaefer-Prokop, CM; Staaks, GH; ter Heine, R; van den Bosch, RT; van den Brand, JJ; van der Westerlaken, MM | 1 |
Hocher, B; Klein, T; Mark, M; Pfab, T; Sharkovska, Y | 1 |
Johansen, OE; Neubacher, D; Patel, S; von Eynatten, M; Woerle, HJ | 1 |
Deng, HW; Hu, CP; Li, NS; Li, YJ; Xiao, L | 1 |
Buyniski, JP; Fleming, JS | 1 |
Baba, K; Fujiwara, H; Kariya, T; Kawai, T; Minatoguchi, S; Takahashi, M; Takemura, G; Uno, Y; Zhang, C | 1 |
Kanazawa, S; Kinoshita, Y; Muramatsu, M; Nomura, S; Yamaguchi, K | 1 |
Deres, P; Gallyas, F; Halmosi, R; Hanto, K; Hideg, K; Kalai, T; Kulcsar, G; Palfi, A; Sumegi, B; Szabados, E; Szereday, Z; Toth, A; Toth, K | 1 |
Baker, JE; Fu, X; Gross, GJ; Hsu, A; Strande, JL; Su, J | 1 |
Alexandris, AT; Kalogeropoulos, CK; Karlas, EN; Kolettis, MT; Tzannetis, GC | 1 |
Kather, H | 1 |
Braunwald, E; Colucci, WS; Holman, BL; Wynne, J | 1 |
Khomenko, VL; Pomerantsev, VP; Vasiuk, IuA | 1 |
Atlas, D; Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D | 1 |
Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL | 1 |
Amsterdam, EA; Awan, NA; Hermanovich, J; Mason, DT; Vera, Z | 1 |
Coma Canella, I; López-Sendón, J | 1 |
Bertolasi, CA; Pérez Baliño, N; Riccitelli, MA; Trongé, J; Villamayor, RM | 1 |
Bazzino, O; Cremades, E; Doval, H; Oliveri, R | 1 |
Mason, DT | 1 |
Costa, PP; Croce, G; Fernandes, P; Permutti, B | 1 |
Doods, HN; van Zwieten, PA; Wu, DM | 1 |
Coma-Canella, I; Jadraque, LM; Lombera, F; Lopez-Sendon, J | 1 |
Awan, NA; Mason, DT; Maxwell, KS; Miller, RR | 1 |
Conely, JM; Hillis, WS; Hutton, I; Langhan, CE; Lawrie, TD | 1 |
Buchanan, JO; Buyniski, JP; Fleming, JS | 1 |
Evdokimov, EI; Stets, VR; Tishkin, VS | 1 |
Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T | 1 |
Abiko, Y; Hara, Y; Ichihara, K | 1 |
Parratt, JR; Winslow, E | 2 |
3 review(s) available for quinazolines and Cardiovascular Stroke
Article | Year |
---|---|
Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fatal Outcome; Gefitinib; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Myocardial Infarction; Pleural Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2012 |
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme.
Topics: Aged; Angina, Unstable; Biomarkers; Blood Glucose; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Evidence-Based Medicine; Female; Glycated Hemoglobin; Hospitalization; Humans; Linagliptin; Male; Middle Aged; Myocardial Infarction; Patient Safety; Proportional Hazards Models; Prospective Studies; Purines; Quinazolines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Treatment Outcome | 2012 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
3 trial(s) available for quinazolines and Cardiovascular Stroke
Article | Year |
---|---|
Long-term therapy of heart failure with prazosin: a randomized double blind trial.
Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Long-Term Care; Male; Middle Aged; Myocardial Infarction; Placebos; Prazosin; Quinazolines; Radionuclide Imaging; Renin | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines | 1982 |
34 other study(ies) available for quinazolines and Cardiovascular Stroke
Article | Year |
---|---|
Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.
Topics: Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Imaging, Three-Dimensional; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Transforming Growth Factor beta; Ventricular Remodeling | 2013 |
Acute myocardial infarction and anagrelide.
Topics: Adult; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Quinazolines | 2013 |
c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Benzodioxoles; Connexin 43; CSK Tyrosine-Protein Kinase; Death, Sudden; Echocardiography; Enzyme Inhibitors; Gap Junctions; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Protein Phosphatase 1; Quinazolines; Reactive Oxygen Species; src-Family Kinases | 2014 |
Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Aspirin; Cardiotonic Agents; Clopidogrel; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Enzyme Induction; Lipoxins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Pyrazoles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Ticagrelor; Ticlopidine; Triazoles; Up-Regulation | 2014 |
Exercise training activates neuregulin 1/ErbB signaling and promotes cardiac repair in a rat myocardial infarction model.
Topics: Animals; Disease Models, Animal; Male; Myocardial Infarction; Neuregulin-1; Oncogene Proteins v-erbB; Physical Conditioning, Animal; Quinazolines; Rats; Rats, Sprague-Dawley; Tyrphostins | 2016 |
Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Enalapril; Enzyme Inhibitors; Fibrosis; Heart Failure; Male; Myocardial Infarction; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2008 |
[Migraine can signal a risk for heart and brain].
Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Female; Humans; Imidazoles; Migraine Disorders; Migraine with Aura; Myocardial Infarction; Piperazines; Quinazolines; Risk Factors; Stroke; Tryptamines | 2009 |
Recurrent myocardial infarction associated with gefitinib therapy.
Topics: Antineoplastic Agents; Carcinoid Tumor; Gefitinib; Humans; Male; Middle Aged; Myocardial Infarction; Neoplasm Metastasis; Quinazolines | 2011 |
The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats.
Topics: Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Linagliptin; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Purines; Quinazolines; Random Allocation; Rats; Rats, Wistar; Xanthines | 2013 |
Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats.
Topics: Alkaloids; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cardiotonic Agents; Creatine Kinase; Heart; Indole Alkaloids; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neurons, Afferent; Organ Size; Quinazolines; Rats; Rats, Wistar | 2003 |
Enhanced platelet aggregability in dogs following myocardial infarction.
Topics: Animals; Blood Platelets; Carrier Proteins; Collagen; Coronary Vessels; Dipyridamole; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extracellular Matrix Proteins; Glycoproteins; Ligation; Myocardial Infarction; Platelet Aggregation; Quinazolines; Sulfinpyrazone | 1977 |
Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Protein Kinase C; Quinazolines; Rabbits; Receptor, Adenosine A1; Receptors, Adrenergic, alpha-1; Staurosporine; Theophylline; Tyramine; Vasodilator Agents | 2005 |
Acute myocardial infarction with lung cancer during treatment with gefitinib: the possibility of gefitinib-induced thrombosis.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Gefitinib; Humans; Lung Neoplasms; Myocardial Infarction; Quinazolines; Thrombosis | 2005 |
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Topics: Animals; Cardiomegaly; Collagen Type III; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Isoproterenol; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Natriuretic Peptide, Brain; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2006 |
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Topics: Androstadienes; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Hirudins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Recombinant Proteins; Research Design; RNA, Messenger; Signal Transduction; Thrombin; Time Factors; Ventricular Function, Left; Wortmannin | 2007 |
Limitation of infarct size by decrease of afterload with prazosin.
Topics: Adult; Aged; Aspartate Aminotransferases; Electrocardiography; Female; Hemodynamics; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines | 1983 |
[Hypertensive therapy with prazosin. Concomitant cardiovascular, metabolic and respiratory diseases. Proven facts and potential aspects].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiovascular Diseases; Diabetes Complications; Humans; Hypertension; Kidney; Lipids; Myocardial Infarction; Prazosin; Quinazolines; Respiratory Tract Diseases | 1984 |
Prazosin therapy for refractory variant angina.
Topics: Aged; Angina Pectoris, Variant; Coronary Vasospasm; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines | 1983 |
Cardiocirculatory actions of trimazosin and sodium nitroprusside in ischemic heart disease.
Topics: Adult; Aged; Cardiac Catheterization; Ferricyanides; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Piperazines; Plethysmography, Impedance; Quinazolines; Vasodilator Agents | 1982 |
[Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction].
Topics: Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Prazosin; Quinazolines | 1981 |
[Vasodilator therapy of pump failure in acute myocardial infarction].
Topics: Adult; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
[Acute myocardial infarction with pump failure: hemodynamic response to prazosin].
Topics: Adult; Aged; Arterioles; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Vasodilator therapy in congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Peripheral resistances in acute myocardial infarction: the use of prazosine versus isosorbide dinitrate.
Topics: Cardiac Output; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Prazosin; Quinazolines; Time Factors; Vascular Resistance | 1980 |
Effects of calcitonin gene-related peptide and BIBN4096BS on myocardial ischemia in anesthetized rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Cardiotonic Agents; Creatine Kinase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Piperazines; Piperidines; Quinazolines; Rats; Rats, Wistar | 2001 |
Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance | 1979 |
Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
Topics: Blood Pressure; Cardiac Output; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Plethysmography, Impedance; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1977 |
Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease.
Topics: Coronary Disease; Hemodynamics; Humans; Male; Myocardial Contraction; Myocardial Infarction; Phosphodiesterase Inhibitors; Piperidines; Quinazolines | 1977 |
The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs.
Topics: Animals; Aspirin; Blood Pressure; Disease Models, Animal; Dogs; Epinephrine; Female; Imidazoles; Male; Myocardial Infarction; Necrosis; Phenoxybenzamine; Platelet Aggregation; Propranolol; Quinazolines | 1976 |
[The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
Topics: Animals; Cardiovascular Agents; Drug Evaluation, Preclinical; Heart; Inosine Diphosphate; Inosine Nucleotides; Isoproterenol; Male; Myocardial Infarction; Myocardium; Pituitary Hormones, Posterior; Quinazolines; Rats; Rats, Inbred Strains | 1989 |
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female; Heart Ventricles; Hemodynamics; Myocardial Infarction; Quinazolines; Rats; Rats, Inbred Strains; Vascular Resistance; Weight Gain | 1989 |
MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
Topics: Acidosis; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Vessels; Dogs; Female; Heart; Hydrogen-Ion Concentration; Male; Myocardial Infarction; Propranolol; Quinazolines; Quinazolinones | 1988 |
The effects of quazodine on myocardial blood flow in developing myocardial infarcts.
Topics: Animals; Blood Pressure; Cardiac Output; Cats; Coronary Circulation; Dogs; Heart Rate; Injections, Intravenous; Myocardial Infarction; Quinazolines | 1971 |
Haemodynamic and coronary effects of quazodine in cats with developing myocardial infarcts.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Body Temperature; Cardiac Output; Cats; Coronary Circulation; Female; Heart Rate; Heart Ventricles; Hemodynamics; Ligation; Male; Myocardial Infarction; Quinazolines; Time Factors; Vascular Resistance | 1972 |